Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Basiliximab as a Treatment of Interstitial Pneumonia in Clinical Amyopathic Dermatomyositis Patients

NCT03192657 is registered in ClinicalTrials.gov with RenJi Hospital as lead sponsor.

NCT NCT03192657
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03192657 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Basiliximab as a Treatment of Interstitial Pneumonia in Clinical Amyopathic Dermatomyositis Patients
Lead sponsor
RenJi Hospital
Phase
Phase 2
Overall status
Unknown status
Start date
July 31, 2017
Completion date
June 30, 2020
Enrollment
100 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

dermatomyositis, lung; disease, interstitial, with fibrosis